Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)

Name: Bioequivalence Study of Empagliflozin & Metformin HCL From Empagliform 12.5/1000 mg F.C.T (Hikma Pharma, Egypt) and Synjardy 12.5/1000 mg F.C.T (Boehringer Ingelheim International GmbH, Germany)
License: Public Domain

Genuine Research Center, Egypt

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

healthy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 126065
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.